Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+6.27%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.29B
Cap. Flow %
-11.94%
Top 10 Hldgs %
11.91%
Holding
4,468
New
544
Increased
1,604
Reduced
1,694
Closed
601

Top Sells

1
AMZN icon
Amazon
AMZN
+$1.17B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$506M
4
ABT icon
Abbott
ABT
+$388M
5
JNJ icon
Johnson & Johnson
JNJ
+$325M

Sector Composition

1 Technology 20.29%
2 Healthcare 16.94%
3 Consumer Discretionary 12.83%
4 Consumer Staples 9.16%
5 Industrials 9.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BCDA icon
3626
BioCardia
BCDA
$12.3M
$47K ﹤0.01%
1,180
+140
+13% +$5.58K
PZG icon
3627
Paramount Gold Nevada
PZG
$73.6M
$47K ﹤0.01%
149,400
-177,600
-54% -$55.9K
XNET
3628
Xunlei
XNET
$454M
$47K ﹤0.01%
23,925
+13,640
+133% +$26.8K
TFFP
3629
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$47K ﹤0.01%
4,020
+716
+22% +$8.37K
FUV
3630
DELISTED
Arcimoto, Inc. Common Stock
FUV
$47K ﹤0.01%
+32,529
New +$47K
IKT icon
3631
Inhibikase Therapeutics
IKT
$115M
$46K ﹤0.01%
12,722
+1,505
+13% +$5.44K
ITRM icon
3632
Iterum Therapeutics
ITRM
$31M
$46K ﹤0.01%
42,784
+3,900
+10% +$4.19K
REFR icon
3633
Research Frontiers
REFR
$43.4M
$46K ﹤0.01%
+29,000
New +$46K
SQFT icon
3634
Presidio Property Trust
SQFT
$7.17M
$46K ﹤0.01%
5,105
+510
+11% +$4.6K
CNTX icon
3635
Context Therapeutics
CNTX
$76.3M
$45K ﹤0.01%
28,300
+9,100
+47% +$14.5K
MYO icon
3636
Myomo
MYO
$33M
$45K ﹤0.01%
86,898
+18,298
+27% +$9.48K
SABS icon
3637
SAB Biotherapeutics
SABS
$22.2M
$45K ﹤0.01%
+5,440
New +$45K
HSDT icon
3638
Helius Medical Technologies
HSDT
$7.38M
$44K ﹤0.01%
+6
New +$44K
IH
3639
iHuman
IH
$150M
$44K ﹤0.01%
14,860
+2,160
+17% +$6.4K
MDNA
3640
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$44K ﹤0.01%
90,400
-59,900
-40% -$29.2K
AREC icon
3641
American Resources Corp
AREC
$172M
$43K ﹤0.01%
21,924
-331,676
-94% -$651K
RZLT icon
3642
Rezolute
RZLT
$705M
$43K ﹤0.01%
21,900
+2,500
+13% +$4.91K
ELYS
3643
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$43K ﹤0.01%
112,008
-22,292
-17% -$8.56K
BDSX icon
3644
Biodesix
BDSX
$76.5M
$42K ﹤0.01%
34,100
-13,900
-29% -$17.1K
OGEN icon
3645
Oragenics
OGEN
$4.7M
$42K ﹤0.01%
424
-136
-24% -$13.5K
TOI icon
3646
The Oncology Institute
TOI
$293M
$42K ﹤0.01%
75,642
-56,858
-43% -$31.6K
BEST
3647
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$42K ﹤0.01%
19,900
+900
+5% +$1.9K
TCON
3648
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$42K ﹤0.01%
7,174
-1,256
-15% -$7.35K
LVOX
3649
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$42K ﹤0.01%
15,400
+3,600
+31% +$9.82K
FORA icon
3650
Forian
FORA
$72.2M
$41K ﹤0.01%
16,915
-3,785
-18% -$9.17K